ID29352A - Penggunaan turunan tiazolidindion untuk mencegah kontraksi uterin dalam persalinan prematur atau laktasi - Google Patents

Penggunaan turunan tiazolidindion untuk mencegah kontraksi uterin dalam persalinan prematur atau laktasi

Info

Publication number
ID29352A
ID29352A IDW00200101157A ID20011157A ID29352A ID 29352 A ID29352 A ID 29352A ID W00200101157 A IDW00200101157 A ID W00200101157A ID 20011157 A ID20011157 A ID 20011157A ID 29352 A ID29352 A ID 29352A
Authority
ID
Indonesia
Prior art keywords
tiazolidindion
lactation
premature
contract
labor
Prior art date
Application number
IDW00200101157A
Other languages
English (en)
Inventor
John A Copland Iii
Kirk L Ives
Melvyn Soloff
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of ID29352A publication Critical patent/ID29352A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IDW00200101157A 1998-10-29 1999-10-29 Penggunaan turunan tiazolidindion untuk mencegah kontraksi uterin dalam persalinan prematur atau laktasi ID29352A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10613398P 1998-10-29 1998-10-29

Publications (1)

Publication Number Publication Date
ID29352A true ID29352A (id) 2001-08-23

Family

ID=22309672

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101157A ID29352A (id) 1998-10-29 1999-10-29 Penggunaan turunan tiazolidindion untuk mencegah kontraksi uterin dalam persalinan prematur atau laktasi

Country Status (19)

Country Link
US (1) US7528133B1 (id)
EP (1) EP1126844A1 (id)
JP (1) JP2002528500A (id)
KR (1) KR20010089381A (id)
CN (1) CN1328456A (id)
AU (1) AU1330800A (id)
BR (1) BR9915820A (id)
CA (1) CA2348910A1 (id)
CZ (1) CZ20011524A3 (id)
HK (1) HK1041213A1 (id)
HU (1) HUP0104900A3 (id)
ID (1) ID29352A (id)
IL (1) IL142841A0 (id)
MX (1) MXPA01004257A (id)
NO (1) NO20012090L (id)
PL (1) PL347508A1 (id)
TR (1) TR200101882T2 (id)
WO (1) WO2000025781A1 (id)
ZA (1) ZA200103999B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062563A2 (en) * 2003-01-16 2004-07-29 Université de Lausanne Methods for screening for therapeutic agents that are useful in the treatment of oxytocin and vasopressin-related disorders
DE10361621A1 (de) 2003-12-30 2005-07-28 Volker Dr. Krieger Modulares Labor auf der Basis genormter Container
US20150004144A1 (en) 2011-12-02 2015-01-01 The General Hospital Corporation Differentiation into brown adipocytes
ES2690782T3 (es) 2012-10-24 2018-11-22 Nyu Winthrop Hospital Biomarcador no invasivo para identificar sujetos en riesgo de parto prematuro
CN109790133A (zh) * 2016-01-04 2019-05-21 奥布赛瓦股份公司 羟丙基噻唑烷羧酰胺衍生物的α-氨基酯及其盐形式、晶体多形体
EP3651756B1 (en) 2017-07-12 2025-09-03 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin
CA3075688A1 (en) 2017-09-13 2019-03-21 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECLAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR TESTS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5370135A (en) * 1993-10-13 1994-12-06 Biex, Inc. Use of estriol measurement to monitor tocolytic therapy
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
EP0783888A1 (en) 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
JP2000511875A (ja) * 1996-06-19 2000-09-12 ドクター・レディーズ・リサーチ・ファウンデーション 抗糖尿病活性を増強されたトログリタゾンの新規な多形型及びそれらの製造方法
US5814647A (en) 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms

Also Published As

Publication number Publication date
PL347508A1 (en) 2002-04-08
JP2002528500A (ja) 2002-09-03
AU1330800A (en) 2000-05-22
BR9915820A (pt) 2001-10-30
US7528133B1 (en) 2009-05-05
CN1328456A (zh) 2001-12-26
IL142841A0 (en) 2002-03-10
HUP0104900A3 (en) 2003-02-28
WO2000025781A1 (en) 2000-05-11
CZ20011524A3 (cs) 2002-01-16
CA2348910A1 (en) 2000-05-11
EP1126844A1 (en) 2001-08-29
HK1041213A1 (zh) 2002-07-05
ZA200103999B (en) 2002-08-16
KR20010089381A (ko) 2001-10-06
NO20012090L (no) 2001-06-27
NO20012090D0 (no) 2001-04-27
TR200101882T2 (tr) 2001-12-21
HUP0104900A2 (hu) 2002-04-29
MXPA01004257A (es) 2002-06-21

Similar Documents

Publication Publication Date Title
ID28947A (id) Metode untuk meringankan inkontinensia uriner wanita
PT1200065E (pt) Composicao de ovulos intravaginais de clindamicina
PT1270565E (pt) Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia
CY2006003I1 (el) Χρηση δαπτομυκινης
AU8270701A (en) Improvements in and relating to the use of honey in dressings
DE69924799D1 (de) Miederhose
HUS1300015I1 (hu) Humán IL-1béta elleni antitestek
ID29767A (id) Pengisolasian zona selektif didalam sulur beralur
ID29021A (id) Komposisi galantamina pelepasan terkontrol
ID27092A (id) Pembuatan ftalat anhidrida
ATE355068T1 (de) Elektrolytgel zur erhaltung der hydration und rehydration
PT1274407E (pt) Utilizacao de agonistas de ppar-gama em doencas induzidas por netrofilos
DE69931855D1 (de) Hautpräparat
EE200100395A (et) (S)-omeprasooli kaaliumisool
BR0012303B1 (pt) composição de gordura
DE69811330D1 (de) Reinigungspflaster zur verbesserung des hautzustandes
EE200000485A (et) Nahal kasutatavad parasititsiidide vett sisaldavad preparaadid
ID29352A (id) Penggunaan turunan tiazolidindion untuk mencegah kontraksi uterin dalam persalinan prematur atau laktasi
FI971742L (fi) Kompetitiivisia progesteroniantagonisteja tarpeen sanelemaan raskaudenehkäisyyn naisilla
ID25765A (id) Komposisi pembersih kulit
EP1452162A4 (en) GEL-COMPOSITE COMPOSITION
NO20000117D0 (no) Hydrerings- og fryseanlegg for fleksible kjoelemedier
FR2784373B1 (fr) Adjuvant liquide et compositions de ciment
FR2743732B1 (fr) Tourniquet aerien pour etre humain
DE69823000D1 (de) Dränageverfahren und Dränagestreifen zur Durchführung des Verfahrens